4 Results for "

1661838-94-3

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "1661838-94-3" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-109018B
CAS No.: 1661838-94-3
Purity:  99.43%
Target:  

SGLT

Research Areas:  

Metabolic Disease

Velagliflozin proline hydrate is the clinical form of Velagliflozin (HY-109018). Velagliflozin is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor with antidiabetic activity. Velagliflozin reduces renal glucose reabsorption and stimulates glycosuria, which lowers blood sugar and insulin concentrations .
loading...
    loading...
Cat. No.: HY-109018BR
CAS No.: 1661838-94-3
Research Areas:  

Metabolic Disease

Velagliflozin proline hydrate (Standard) is the analytical standard of Velagliflozin (proline hydrate) (HY-109018B). This product is intended for research and analytical applications. Velagliflozin proline hydrate is the clinical form of Velagliflozin (HY-109018). Velagliflozin is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor with antidiabetic activity. Velagliflozin reduces renal glucose reabsorption and stimulates glycosuria, which lowers blood sugar and insulin concentrations .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-109018
CAS No.: 946525-65-1
Purity:  99.76%
Target:  

SGLT

Research Areas:  

Metabolic Disease

Velagliflozin is an orally available sodium-glucose cotransporter 2 (SGLT2) inhibitor, with anti-diabetic activity.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-109018A
CAS No.: 1539295-26-5
Purity:  99.43%
Target:  

SGLT

Research Areas:  

Metabolic Disease

Velagliflozin proline is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor with antidiabetic activity. Velagliflozin proline reduces renal glucose reabsorption and stimulates glycosuria, which lowers blood sugar and insulin concentrations .
loading...
    loading...